Search & Analyze
Popular Searches
Medicamen Biotech Ltd.
Healthcare₹243.254.78%
24 Jul, 4:01 PM
CMP₹243.25
Mkt Cap₹323 Cr
P/E33.52
P/B1.20
ROE3.23%
52W High₹454.00
52W Low₹216.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
33.52
P/B Ratio
1.20
EV/EBITDA
14.97
Price/Sales
1.63
Dividend Yield (%)
0.42
EPS (TTM ₹)
7.11
Book Value (₹)
198.16
ROE (%)
3.23
ROCE (%)
5.77
ROA (%)
2.24
EBITDA Margin (%)
8.87
Net Profit Margin (%)
4.03
Debt/Equity
0.16
Current Ratio
2.11
Interest Coverage
3.66
Asset Turnover
0.55
Working Capital/Sales
1.88
Core EBITDA Growth (%)
-20.02
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 1127160827 | 11544.53 | 14086.74 | 17930.62 | 16254.72 |
| Net Sales | 1127160827 | 11544.53 | 14086.74 | 17930.62 | 16254.72 |
| Total Income | 1134701285 | 11716.55 | 14332.96 | 18163.22 | 16879.62 |
| Total Expenditure | 930448810 | 9135.82 | 11652.61 | 15579.16 | 14812.96 |
| Operating Profit | 204252475 | 2580.73 | 2680.35 | 2584.06 | 2066.66 |
| Depreciation | 25197131 | 577.14 | 636.66 | 709.32 | 706.61 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 163940121 | 1809.48 | 1704.5 | 1307.56 | 988 |
| Tax | 42645722 | 319.71 | 231.65 | 358.16 | 332.43 |
| Profit After Tax (PAT) | 121294399 | 1489.77 | 1472.85 | 949.4 | 655.57 |
| EPS (₹) | 9.93 | 12.19 | 11.64 | 7.5 | 5.16 |
| Dividend Payout % | 10 | 10 | 10 | 10 | 10 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 122166000 | 1221.66 | 1265.11 | 1271.46 | 1271.46 |
| Reserves | 1206729481 | 13425.31 | 17815.75 | 19426.97 | 20033.84 |
| Shareholders Funds | 1328895481 | 14646.97 | 19341.41 | 20698.43 | 21305.3 |
| Total Debt | 188193393 | 2579.59 | 2570.9 | 3111.15 | 3377.42 |
| Total Liabilities | 1940070830 | 22519.71 | 27663.78 | 29203.62 | 29432.06 |
| Total Assets | 1940070830 | 22519.71 | 27663.78 | 29203.62 | 29432.06 |
| Book Value / Share | 103.3257 | 113.5606 | 145.2456 | 157.5192 | 162.2297 |
| Assets | 1940070830 | 22519.71 | 27663.78 | 29203.62 | 29432.06 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 127715706 | 410.91 | -629.28 | -674.38 | -815.88 |
| Investing Activities | -178126048 | -847.28 | -588.04 | -556.29 | -139.68 |
| Financing Activities | 58388850 | 429.79 | 2912.73 | 631.35 | -147.06 |
| Net Cash Flow | 7978508 | -6.58 | 1695.41 | -599.32 | -1102.62 |
MEDICAMEQ
₹243.25
+4.78%